# GeneLink, Inc. (GNLKQ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GNLKQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2013 | $ 1.87M | $ -1.73M | $ -521.8K | $ 1.19M | $ -3.20M |
| 2012 | $ 3.08M | $ -4.41M | $ -3.79M | $ 0 | $ -2.66M |
| 2011 | $ 6.88M | $ -5.73M | $ -4.32M | N/A | $ -1.48M |
| 2010 | $ 11.87M | $ -3.71M | $ -2.19M | N/A | $ -789.9K |
| 2009 | $ 12.96M | $ -4.19M | $ -4.04M | N/A | $ -739.8K |
| 2008 | $ 9.65M | $ -3.93M | $ -2.62M | N/A | $ 52.2K |
| 2007 | $ 148.0K | $ -2.36M | $ -1.21M | $ 506.0K | $ 193.4K |
| 2006 | $ 266.0K | $ -899.2K | $ -588.4K | $ 316.4K | $ -859.3K |
| 2005 | $ 607.8K | $ -1.60M | $ -664.6K | $ 27.9K | $ -612.6K |
| 2004 | $ 462.4K | $ -3.20M | $ -1.96M | $ 213.9K | $ -199.3K |
| 2003 | $ 194.1K | $ -1.79M | $ -1.57M | $ 33.0K | $ 740.5K |
| 2002 | $ 96.0K | $ -2.23M | $ -1.31M | $ 53.0K | $ -362.2K |
| 2001 | $ 25.8K | $ -1.34M | $ -301.5K | $ 58.0K | $ -150.8K |
| 2000 | $ 56.5K | $ -1.36M | $ -480.4K | $ 492.0K | $ -698.2K |
| 1999 | $ 5.3K | $ -208.3K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.37 |
| Liabilities / Eq | -1.40 |
| Current Ratio | 0.34 |

## Other views

- [Metrics](https://sponda.capital/en/GNLKQ.md)
- [Charts](https://sponda.capital/en/GNLKQ/charts.md)
- [Compare](https://sponda.capital/en/GNLKQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.